Adjustment of the area under the concentration curve by terminal rate constant for bioequivalence assessment in a parallel‐group study of lamotrigine-Reference-Cited by-同舟云学术

Adjustment of the area under the concentration curve by terminal rate constant for bioequivalence assessment in a parallel‐group study of lamotrigine

Published:2019-01-17 Issue:3 Volume:85 Page:563-569
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Yang Jiansong¹,Ma Peiming¹,Bullman Jonathan²,Nicholls Andrew²,Chen Chao²^ORCID

Affiliation:

1. GlaxoSmithKline R&D Shanghai China

2. GlaxoSmithKline R&D London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13826

Reference29 articles.

1. GlaxoSmithKline.Lamictal IR prescribing information 2015[online]. Available athttps://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020241s053 020764s046 022251s017lbl.pdf(last accessed 20 December 2018).

2. GlaxoSmithKline.Lamictal XR prescribing information 2015[online]. Available athttps://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022115s011s018lbl.pdf(last accessed 20 December 2018).

3. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels

4. Enhancement of solubility of lamotrigine by solid dispersion and development of orally disintegrating tablets using 32 full factorial design;Singh J;J Pharm,2015

5. Steady-state Pharmacokinetics of Lamotrigine when Converting from a Twice-daily Immediate-release to a Once-daily Extended-release Formulation in Subjects with Epilepsy (The COMPASS Study)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling;The AAPS Journal;2022-01

2. Evaluation of the estimation and classification performance of NONMEM when applying mixture model for drug clearance;CPT: Pharmacometrics & Systems Pharmacology;2021-10-24

3. Evaluation of area under the concentration curve adjusted by the terminal‐phase as a metric to reduce the impact of variability in bioequivalence testing;British Journal of Clinical Pharmacology;2021-08-24

4. Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help;Biopharmaceutics & Drug Disposition;2021-04